Makers Labs share price is Up ▲ 8.72% on 20-Sep-2024

Makers Labs share price is Up ▲ 8.72% on 20-Sep-2024. | 18.61k shares traded.
Its CMP is Rs 168.35 and MCap is approx : 99 Crores.
The stock is up ▲ 7.8% in 7 days,
down ▼ -1.8% in 1 month
and up ▲ 31.9% in 2 months.
Please click image for Latest Daily data.
Makers Labs results Mar 2023 (Standalone_YoY) revenue elevated to 10.8 crores up 20% in Mar 2023 quarter, compared with 9 crores in Mar 2022. Its Net loss is -0.8 crores up 50% in Mar 2023 quarter, compared with -1.6 crores in last year same quarter. Please click Image for Daily Data and results of the stock.
* Data updated everyday at 7pm. Only Data. Not Buy or Sell advice.

Click Image for Data | Scroll down for Comments

About Makers Labs :

Founded: 1984
Headquarters: India
Number of employees: 121 (2023)
Subsidiary: Harleystreet Pharmaceuticals Ltd

Makers Laboratories Limited is an Indian pharmaceutical company that focuses on branded generics. The company was founded in 1984 and is headquartered in Mumbai, Maharashtra. Makers Laboratories Limited’s product portfolio includes general health therapeutic segments, such as Duramol (Paracetamol), Artemak-AB (α-β Arteether), Loroquin (Chloroquine), Nimuwin (Nimuselide), Coffwin (Anti cough Range), and Exylin (Amoxycillin range).

Makers Laboratories Limited has launched new ranges of diabetic and hypertensive drugs, including Voglibose Gli-me range (Glimepiride + Metformin + Pioglitazone) and Hypernorm range (Telmisartan). The company also started manufacturing ophthalmic eye drops in Ahmedabad in 2021.
—————————————————-
* About company information is from various sources on the internet ( March 2024 ).
Please verify the official website of company for the latest updated information.
—————————————————-

Please visit